BioTech Medics, Inc. Featured at Fat Cat Club Quarterly Meeting in Las Vegas
05 August 2009 - 3:28AM
Marketwired
BioTech Medics, Inc. (PINKSHEETS: BMCS) announces Keith Houser,
Chairman/CEO, will be presenting at the Quarterly Fat Cat Club
Meeting at the Bellagio in Las Vegas on Thursday, August 13, 2009.
The Fat Cat Club is a national accredited investor angle network
that meets quarterly to review investment opportunities. Membership
is free to highly accredited investors; however guest attendees
will be required to pay a one-time $99.00 fee for the Bellagio
meeting and luncheon at Noon.
BioTech Medics, Inc. is a 12-year-old Nevada corporation that
owns, operates and/or has affiliated Pain Management & Wellness
Centers utilizing high powered deep penetrating FDA 510(k) cleared
therapeutic medical lasers that reduce or eliminate muscle, nerve,
skeletal and/or arthritic pain.
Frank Spady, Founder/CEO of Self-Directed Alliance of Las Vegas,
will also be presenting with BioTech Medics on how you can
self-direct 401(k), IRA and even Health Savings Accounts in
BioTech. Mr. Spady was formerly CEO of Provident Group, a trust
with over 8,000 clients. He previously worked as a Sr. VP of Sales
with Boeing Computers and was the Exec. Director of the Nevada
Association of Mortgage Brokers.
"If you are an accredited investor or one who has been laid off,
a doctor, chiropractor, spa owner, displaced automobile dealer or a
person with management experience wanting to make a change in your
life, plan on attending this informative presentation," said Mr.
Spady.
BioTech also has 4 US Letters of Patent for SHBAN(TM)
Antimicrobial Hand Sanitizer that has been clinically proven to
kill the Avian Bird Flu and is currently being tested to prove
SHBAN's efficacy in killing the H1N1 (Swine) Influenza A. SHBAN
does not contain alcohol and is 98% organic and biodegradable
without harming humans or animals.
Safe Harbor: Forward-Looking Statements
This release contains forward-looking statements within the
meaning of The Private Securities Litigation Reform Act of 1995
(the "Act"). This is not an offer to buy or sell any security in
any jurisdiction. Any offering or solicitation will be made only to
qualified prospective investors pursuant to a confidential offering
memorandum, and the subscription documents. The statements above
have not been evaluated by the FDA. SHBAN is not intended to
diagnose, treat or cure any disease.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: Dawn Gouge 817-343-7783 Email Contact Ben Doherty
214-558-9798 Email Contact
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Jun 2024 to Jul 2024
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Jul 2023 to Jul 2024